Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2023 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Rifadin for Infusion 600 mg.
Pharmaceutical Form |
---|
Lyophilisate (for reconstitution prior to use) and accompanying ampoule of solvent. |
Rifampicin BP 600 mg.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Rifampicin |
Rifampicin is an active bactericidial antituberculosis drug which is particularly active against the rapidly growing extracellular organisms and also has bactericidial activity intracellularly. Rifampicin inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. |
List of Excipients |
---|
Sodium sulfoxylate formaldehyde Solvent: Water for injections |
20ml clear neutral glass vial sealed with butyl rubber stopper and aluminium/plastic “flip-off” cap (colour coded blue) containing 600mg Rifampicin and 10ml clear glass ampoule containing solvent.
Pack size: combination of 1 vial of lyophilisate and 1 ampoule of solvent.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0051
Date of First Authorisation: 15 December 1982
Date of latest renewal: 09 April 2005
Drug | Countries | |
---|---|---|
RIFADIN | Australia, Estonia, Hong Kong, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.